Financing ·
Disc Medicine, Inc. entered into a First Amendment to its Loan and Security Agreement with Hercules Capital, Inc. to…
IRONDisc Medicine, Inc.
Disc Medicine, Inc. entered into a First Amendment to its Loan and Security Agreement with Hercules Capital, Inc. to extend drawing periods for future Advances. The Company agreed to draw down $30,000,000 of the Tranche 1-B Advance, restructured the existing $50,000,000 Tranche 1-C Advance into two $25,000,000 portions, and extended the drawing periods for Tranche 2 and Tranche 3 Advances to December 15, 2027, and June 30, 2028, respectively. The amendment also modified minimum cash covenant testing to an initial date of July 1, 2028. Disc Medicine, Inc. is a biotechnology company focused on developing medical treatments for rare diseases.